T 1780/12 (Cancer treatment/BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM) of 30.1.2014

European Case Law Identifier: ECLI:EP:BA:2014:T178012.20140130
Date of decision: 30 January 2014
Case number: T 1780/12
Application number: 04007843.8
IPC class: A61K 39/395
A61K 51/10
A61K 47/48
A01K 67/027
C07K 16/00
C07K 16/28
Language of proceedings: EN
Distribution: B
Download and more information:
Decision text in EN (PDF, 443 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Uses of antibodies to aminophospholipids for cancer treatment
Applicant name: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Opponent name: -
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 111(1)
Keywords: Double patenting (no) - not the same subject-matter
Remittal to the department of first instance - (yes)
Catchwords:

See points 16 to 25 of the Reasons

Cited decisions:
G 0005/83
G 0002/88
G 0001/05
G 0001/06
G 0002/08
T 0250/05
T 0795/06
T 0877/06
T 1391/07
T 1635/09
T 2402/10
Citing decisions:
T 1021/11
T 1155/11
T 1483/11
T 1673/11
T 0879/12
T 0013/14
T 0015/14
T 0318/14

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t121780eu1.html

Date retrieved: 17 May 2021

22 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law